These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11245856)

  • 1. GPI 6150, a poly (ADP-ribose) polymerase inhibitor, exhibits an anti-inflammatory effect in rat models of inflammation.
    Mazzon E; Serraino I; Li JH; Dugo L; Caputi AP; Zhang J; Cuzzocrea S
    Eur J Pharmacol; 2001 Mar; 415(1):85-94. PubMed ID: 11245856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation.
    Cuzzocrea S; Zingarelli B; Gilad E; Hake P; Salzman AL; Szabó C
    Eur J Pharmacol; 1998 Jan; 342(1):67-76. PubMed ID: 9544794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat.
    Mazzon E; Dugo L; Li JH; Di Paola R; Genovese T; Caputi AP; Zhang J; Cuzzocrea S
    Biochem Pharmacol; 2002 Jul; 64(2):327-37. PubMed ID: 12123754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy.
    Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Li JH; Zhang J; Smulson ME
    Nucleic Acids Res; 2001 Feb; 29(3):841-9. PubMed ID: 11160908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of poly (ADP-ribose) synthase inhibitors in zymosan-activated plasma induced paw edema.
    Cuzzocrea S; Costantino G; Zingarelli B; Caputi AP
    Life Sci; 1999; 65(9):957-64. PubMed ID: 10465355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) polymerase-1 inhibitor modulates T regulatory and IL-17 cells in the prevention of adjuvant induced arthritis in mice model.
    Ahmad SF; Zoheir KM; Bakheet SA; Ashour AE; Attia SM
    Cytokine; 2014 Aug; 68(2):76-85. PubMed ID: 24845796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly(ADP-ribose) polymerase.
    Zhang J; Lautar S; Huang S; Ramsey C; Cheung A; Li JH
    Biochem Biophys Res Commun; 2000 Nov; 278(3):590-8. PubMed ID: 11095954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of prostaglandin production by inhibition of poly (ADP-ribose) synthase in carrageenan-induced pleurisy.
    Cuzzocrea S; Sautebin L; Costantino G; Rombolà L; Mazzon E; Caputi AP
    Life Sci; 1999; 65(12):1297-304. PubMed ID: 10503945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects.
    Szabó C; Lim LH; Cuzzocrea S; Getting SJ; Zingarelli B; Flower RJ; Salzman AL; Perretti M
    J Exp Med; 1997 Oct; 186(7):1041-9. PubMed ID: 9314553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury.
    Cuzzocrea S; McDonald MC; Mazzon E; Dugo L; Serraino I; Threadgill M; Caputi AP; Thiemermann C
    Biochem Pharmacol; 2002 Jan; 63(2):293-304. PubMed ID: 11841805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicaraven on nitric oxide-related pathways and in shock and inflammation.
    Zingarelli B; Scott GS; Hake P; Salzman AL; Szabo C
    Shock; 2000 Feb; 13(2):126-34. PubMed ID: 10670842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase.
    Mabley JG; Jagtap P; Perretti M; Getting SJ; Salzman AL; Virág L; Szabó E; Soriano FG; Liaudet L; Abdelkarim GE; Haskó G; Marton A; Southan GJ; Szabó C
    Inflamm Res; 2001 Nov; 50(11):561-9. PubMed ID: 11766996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice.
    Ahmad SF; Zoheir KM; Ansari MA; Korashy HM; Bakheet SA; Ashour AE; Al-Shabanah OA; Al-harbi MM; Attia SM
    Mol Immunol; 2015 Feb; 63(2):394-405. PubMed ID: 25304310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats.
    LaPlaca MC; Zhang J; Raghupathi R; Li JH; Smith F; Bareyre FM; Snyder SH; Graham DI; McIntosh TK
    J Neurotrauma; 2001 Apr; 18(4):369-76. PubMed ID: 11336438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis.
    Wang J; Hao L; Wang Y; Qin W; Wang X; Zhao T; Liu Y; Sheng L; Du Y; Zhang M; Lu Q
    Mol Med Rep; 2015 Mar; 11(3):1768-76. PubMed ID: 25412407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleterious poly(ADP-ribose)polymerase-1 pathway activation in traumatic brain injury in rat.
    Besson VC; Croci N; Boulu RG; Plotkine M; Marchand-Verrecchia C
    Brain Res; 2003 Oct; 989(1):58-66. PubMed ID: 14519512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine.
    Geraets L; Haegens A; Weseler AR; Brauers K; Vernooy JH; Wouters EF; Bast A; Hageman GJ
    Eur J Pharmacol; 2010 Mar; 629(1-3):132-9. PubMed ID: 19962977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 response.
    Gonzalez-Rey E; Martínez-Romero R; O'Valle F; Aguilar-Quesada R; Conde C; Delgado M; Oliver FJ
    PLoS One; 2007 Oct; 2(10):e1071. PubMed ID: 17971849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Maffia P; Patel NS; Di Paola R; Ialenti A; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Eur J Pharmacol; 2004 Jan; 483(1):79-93. PubMed ID: 14709329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.